3 Best Cheap Stocks Under $10 to Buy Now, According to AnalystsTip Ranks·Jun 5 at 04:08 PMCTMX-2.70%DC-0.64%
CytomX Secures $37M Regeneron Pact; Analyst Sets Price Target At $11nasdaq·Jun 4 at 08:55 AMCTMX-2.70%REGN+0.63%
Regeneron and CytomX extend cancer therapy partnership to $4bn dealPharmaceutical Technology·Jun 4 at 03:21 AMCTMX-2.70%REGN+0.63%
HC Wainwright Analysts Increase Earnings Estimates for CTMXMarket Beat·May 13 at 07:08 AMCTMX-2.70%BBH-0.23%
CytomX Therapeutics: Early-Stage Pipeline, Trial Setbacks and High Risks on the Road to ProfitabilityTip Ranks·May 9 at 01:01 AMCTMX-2.70%XBI-1.15%
Cytomx Therap | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 10.26 MEarnings Watch·May 7 at 03:22 PMCTMX-2.70%
CytomX Therapeutics (CTMX) Expected to Announce Quarterly Earnings on ThursdayMarket Beat·May 2 at 01:25 AMCTMX-2.70%XBI-1.15%
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Receives Consensus Rating of "Moderate Buy" from AnalystsMarket Beat·Apr 30 at 03:43 AMCTMX-2.70%FBT-0.57%
Cytomx Therap | 10-K: FY2025 Revenue Misses Estimate at USD 76.2 MEarnings Watch·Apr 24 at 04:23 AMCTMX-2.70%
